How can I submit a competing application for ARRA or other NIH initiatives proposing the use of human embryonic stem cells (hESC), pending the issuance of NIH Guidelines for hESC?
In accord with the NIH Guidance issued April 17, 2009 (NOT-OD-09-085), NIH will accept competing applications for research proposing to use hESC during the period of the development of the NIH Guidelines for hESC. The review and funding of these applications will be deferred until NIH issues final Guidelines. Such applications should identify illustrative cells for the purposes of the research plan. The yes/no hESC stem cell checkboxes should be checked appropriately (this is item 4 on the PHS 398 cover page supplement for electronic submissions using the SF 424 (R&R); for paper submissions this is at the end of PHS 398 Form Page 2). Additionally, applicants should indicate in the appropriate checkbox that the specific stem cell line to be used cannot be referenced at this time. As indicated in the Notice, once the Guidelines have been issued in final applicants will have the opportunity to revise their application as necessary to comply with the Guidelines, including utilization of el
- How can I submit a competing application for ARRA or other NIH initiatives proposing the use of human embryonic stem cells (hESC), pending the issuance of NIH Guidelines for hESC?
- How will NIH consider ARRA administrative supplement requests, pending the issuance of NIH Guidelines for human embryonic stem cells (hESC)?
- Which LEAs should submit data using ARRA Recipient Reporting Application?